[HTML][HTML] Cost-effectiveness of interventions for the prevention and control of COVID-19: Systematic review of 85 modelling studies
L Zhou, W Yan, S Li, H Yang, X Zhang, W Lu… - Journal of Global …, 2022 - ncbi.nlm.nih.gov
Background We aimed to quantitatively summarise the health economic evaluation
evidence of prevention and control programs addressing COVID-19 globally. Methods We …
evidence of prevention and control programs addressing COVID-19 globally. Methods We …
[HTML][HTML] Economic evaluation of COVID-19 vaccination: A systematic review
AM Utami, F Rendrayani, QA Khoiry… - Journal of global …, 2023 - ncbi.nlm.nih.gov
Background Safe and effective vaccination is considered to be the most critical strategy to
fight coronavirus disease 2019 (COVID-19), leading to individual and herd immunity …
fight coronavirus disease 2019 (COVID-19), leading to individual and herd immunity …
Economic evaluation of strategies against coronavirus: a systematic review
R Izadi, N Hatam, F Baberi, S Yousefzadeh… - Health Economics …, 2023 - Springer
Background The COVID-19 outbreak was defined as a pandemic on 11 March 2020 by the
World Health Organization. After that, COVID-19 has enormously influenced health systems …
World Health Organization. After that, COVID-19 has enormously influenced health systems …
Prevalence and factors associated with not receiving the booster dose of the COVID-19 vaccine in adults in Latin America and the Caribbean
D Urrunaga-Pastor, D Fernandez-Guzman… - Travel Medicine and …, 2022 - Elsevier
Background Booster doses have been described as effective in reducing hospitalizations
and deaths from the new variants. However, its coverage is heterogeneous in Latin America …
and deaths from the new variants. However, its coverage is heterogeneous in Latin America …
Analyzing the emerging patterns of SARS‐CoV‐2 Omicron subvariants for the development of next‐gen vaccine: An observational study
Abstract Background and Aim Understanding the prevalence and impact of SARS‐CoV‐2
variants has assumed paramount importance. This study statistically analyzed to effectively …
variants has assumed paramount importance. This study statistically analyzed to effectively …
Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States
M Di Fusco, K Marczell, KA Deger… - Journal of Medical …, 2022 - Taylor & Francis
Background As the body of evidence on COVID-19 and post-vaccination outcomes
continues to expand, this analysis sought to evaluate the public health impact of the Pfizer …
continues to expand, this analysis sought to evaluate the public health impact of the Pfizer …
Cost‐effectiveness of COVID‐19 vaccination: A systematic review
Y Fu, J Zhao, P Han, J Zhang, Q Wang… - Journal of Evidence …, 2023 - Wiley Online Library
Objective The COVID‐19 vaccination strategy has been widely used to protect population
health worldwide. This study aims to summarize the cost‐effectiveness evidence of …
health worldwide. This study aims to summarize the cost‐effectiveness evidence of …
[HTML][HTML] Critical timing and extent of public health interventions to control outbreaks dominated by SARS-CoV-2 variants in Australia: a mathematical modelling study
Objectives The exact characteristics of a coronavirus disease 2019 (COVID-19) outbreak
that trigger public health interventions are poorly defined. The aim of this study was to …
that trigger public health interventions are poorly defined. The aim of this study was to …
Shared-care models are highly effective and cost-effective for managing chronic hepatitis B in China: reinterpreting the primary care and specialty divide
Background We evaluate the impact and cost-effectiveness of shared primary-specialty
chronic hepatitis B (CHB) care models in China. Methods We constructed a decision-tree …
chronic hepatitis B (CHB) care models in China. Methods We constructed a decision-tree …
Comparison of Humoral Response between Third and Fourth Doses of COVID-19 Vaccine in Hemodialysis Patients
Y Joo, DK Kim, YG Jeon, AR Kim, HN Do, SY Yoon… - Vaccines, 2023 - mdpi.com
Dialysis patients are more likely to die or become hospitalized from coronavirus disease
2019 (COVID-19). Currently, only a few studies have evaluated the efficacy of a fourth …
2019 (COVID-19). Currently, only a few studies have evaluated the efficacy of a fourth …